Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 16 studies | 57% ± 15% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 7 studies | 29% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 5824.55 | 2625 / 2642 | 86% | 22.42 | 603 / 705 |
| liver | 99% | 1923.84 | 223 / 226 | 34% | 2.42 | 138 / 406 |
| skin | 0% | 0.78 | 5 / 1809 | 28% | 6.87 | 134 / 472 |
| kidney | 13% | 49.29 | 12 / 89 | 14% | 0.35 | 130 / 901 |
| stomach | 0% | 0 | 0 / 359 | 9% | 0.26 | 26 / 286 |
| thymus | 0% | 0.51 | 1 / 653 | 6% | 0.15 | 36 / 605 |
| esophagus | 0% | 0 | 0 / 1445 | 6% | 0.21 | 11 / 183 |
| intestine | 0% | 0.86 | 2 / 966 | 5% | 0.15 | 27 / 527 |
| bladder | 0% | 0 | 0 / 21 | 3% | 0.10 | 15 / 504 |
| uterus | 0% | 0 | 0 / 170 | 3% | 0.12 | 13 / 459 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.06 | 1 / 45 |
| lung | 0% | 0 | 0 / 578 | 2% | 0.05 | 25 / 1155 |
| breast | 0% | 0 | 0 / 459 | 1% | 0.03 | 14 / 1118 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
| pancreas | 0% | 0 | 0 / 328 | 1% | 0.02 | 2 / 178 |
| spleen | 0% | 1.17 | 1 / 241 | 0% | 0 | 0 / 0 |
| ovary | 0% | 0 | 0 / 180 | 0% | 0.00 | 1 / 430 |
| adipose | 0% | 0.40 | 2 / 1204 | 0% | 0 | 0 / 0 |
| heart | 0% | 0.43 | 1 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.45 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
| blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0051246 | Biological process | regulation of protein metabolic process |
| GO_0006508 | Biological process | proteolysis |
| GO_0005829 | Cellular component | cytosol |
| GO_0005576 | Cellular component | extracellular region |
| GO_0070573 | Molecular function | metallodipeptidase activity |
| GO_0004180 | Molecular function | carboxypeptidase activity |
| GO_0016805 | Molecular function | dipeptidase activity |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | CNDP1 |
| Protein name | Beta-Ala-His dipeptidase (EC 3.4.13.20) (CNDP dipeptidase 1) (Carnosine dipeptidase 1) (Glutamate carboxypeptidase-like protein 2) (Serum carnosinase) Carnosine dipeptidase 1 |
| Synonyms | UNQ1915/PRO4380 CN1 CPGL2 |
| Description | FUNCTION: Catalyzes the peptide bond hydrolysis in Xaa-His dipeptides, displaying the highest activity toward carnosine (beta-alanyl-L-histidine) and anserine (beta-alanyl-3-methyl-histidine). . |
| Accessions | J3QQM7 ENST00000582365.1 Q96KN2 ENST00000584316.5 J3KRP0 ENST00000358821.8 |